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Abstract
Introduction: Urinary stone disease is the third most common affliction of the urinary tract that has 
been associated with an increasing incidence. Over decades, great advances have been made in the 
minimally invasive treatment of urinary stones. Recently, transurethral lithotripsy (TUL) by holmium 
laser was introduced as a possible therapeutic option. This study evaluated the effect of propofol on 
the success rate of TUL by holmium laser.
Methods:  A double-blind randomized controlled trial was conducted on 180 patients to investigate 
the effect of propofol on the success and complication rate of TUL by holmium laser. The enrolled 
patients were divided into two groups: the first group received sodium thiopental (n = 89) while the 
second group received propofol (n = 91). The two groups were compared in terms of the fluctuations 
of systolic blood pressure (SBP), diastolic blood pressure (DBP), heart rate (HR), operation time, 
future stone-free rate (SFR), stone migration, post-operative fever, and ureteral complications such 
as perforation and mucosal damage. Other developed complications were also recorded. After data 
gathering, statistical analysis was performed with SPSS version 21.
Results: the patients’ data such as age, sex, stone diameter, stone laterality, duration of stone impaction, 
primary SBP, DBP and HR were not significantly different between the two groups (P > 0.05). TUL 
and anesthesia duration, first-minute and fifth-minute SBP and DBP, and also changes of HR were 
significantly lower in the propofol group compared with the sodium thiopental group (P < 0.001). 
Moreover, SFR of TUL was more evident in the propofol group. Ureteral mucosal damage was 
significantly less in the propofol group. 
Conclusion: Propofol was associated with a higher reduction in SBP and DBP, decreased duration of 
TUL, fewer fluctuations in HR, and an increased success rate of stone removal by TUL with holmium 
laser.
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Introduction
Urinary stones are the third most prevalent disease of the 
urinary tract.1 The frequency of this condition varies in 
different regions with a prevalence rate of 1%-5% in Asia, 
5%-9% in Europe and 3% in Northern America, and it 
is growing by approximately 0.5% per year in the normal 
population of the United States of America and Europe.2
Currently, treatment protocols mainly focus on the 
prevention of new kidney stone formation and also 
inhibiting the enlargement of existing stones.3
The stone site has a major impact on the symptoms 
of acute renal colic.4 Over decades, great advances have 
been made in the minimally invasive treatment of ureteral 
stones.5-7 Recent therapeutic options include transurethral 
lithotripsy (TUL) by holmium laser, extracorporeal shock 
wave lithotripsy (ESWL) for proximal ureteral stones, and 
laparoscopic lithotripsy.5,8,9
With advances in laser technology, a wide range of laser 
settings and techniques that help in stone removal are 
available to surgeons.10-12
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Stone removal with ureteroscope is most effective in 
treating lower ureteral stones.4 In the setting of acute 
ureteral colic, ureteral spasms make the passage of 
the guide wire of the ureteroscope difficult.5 However, 
applying local lidocaine gel, aminophylline 5%, or 
intravenous Buscopan® can reduce ureteral spasms and 
increase the rate of successful ureteroscopy.13
Propofol is a hypnotic drug from the alkylphenol group 
used for anesthesia and sedation during intensive care 
and surgery.14 In recent years, the use of propofol without 
muscle relaxants during laryngoscopy, intubation, and 
insertion of the laryngeal mask has been widely studied, 
showing that applying propofol without muscle relaxants 
induces smooth muscle relaxation during procedures.15
Based on this finding, the effect of propofol on 
decreasing muscle tone was approved, but the effect of 
this drug on ureteral spasm, tissue injury, and the success 
rate of TUL by holmium laser had not been studied. 
This study aimed to assess the effect of propofol on 
decreasing ureteral spasm, possibly leading to successful 
ureteroscopy and TUL by holmium laser.
Methods
Study Population
Participants with a mean age of 34.3 ± 4.9 and an established 
diagnosis of renal colic and a distal ureteral stone were 
enrolled in this study. All patients had been referred to 
Shohada-e-Tajrish hospital between September 2016 and 
October 2017 for TUL operation. The exclusion criteria 
were: pregnancy, history of previous TUL, functional or 
anatomical renal disorders, difficult stenting, pulmonary 
disease, smoking, addiction, concurrent corticosteroid 
therapy, and allergy to propofol, egg, and soya.
Study Protocol
This study was designed as a double-blind clinical trial. 
After approval of our institutional review board, 180 
patients were included in this prospective study and 
they received individual codes. Using computer-based 
software, the patients were randomly divided into two 
groups (Figure 1). To ensure blinding, the following 
method was used: an anesthesia technician loaded needles 
with a certain volume of each drug and labeled the needles 
with A or B. Then, according to a random number table, 
the needles were delivered to the blinded anesthesiologist. 
Furthermore, the surgeon and his/her assistant were not 
aware of the type of hypnotic drug used during TUL by 
holmium laser.
First, 1.5 mg/kg lidocaine, 2 μg/kg fentanyl and 0/02 
mg/kg midazolam were administered to all patients 
to induce sedation and then 2.5 mg/kg propofol was 
prescribed for group one (propofol group) and 5mg/kg 
sodium thiopental was prescribed for group two (sodium 



























Patients with ureter stones referred to 
Shohada-e-Tajrish hospital from 
September 2016 to October 2017 for TUL 
operation (n=210) 
Exclusion criteria: pregnancy, history of 
previous TUL, functional or anatomical 
renal disorders, difficult stenting, 
pulmonary disease, smoking, 
addiction, concurrent corticosteroid 
therapy, and allergy to propofol, egg, 
and soya. 
Patients excluded from 
the study 
(n=30) 
Patients included in the 
study  
(n = 180 ) 
Sodium thiopental group  
(n = 89 ) 
Propofol group  
(n = 91) 
Double-blinded 
randomization  
(n =   ) 
Figure 1. Study Protocol.
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inserted for both groups and inhalatory O2, N2O 50% (3 
L/min), and 1%-2% MAC sevoflurane were administered 
for all patients. Ureteroscopy was performed with a 9.5F 
semi-rigid ureteroscope in the lithotomy position (Wolf 
Inc., Germany). The Ho:YAG laser (manufactured in Iran) 
was used for lithotripsy. After stone visualization, the laser 
fiber (500 Mm) was crossed through the working channel 
of the ureteroscope, and then the laser was discharged. 
Laser lithotripsy continued until stone fragments became 
as small as sand particles. A single urologist performed 
ureteroscopy combined with the Ho: YAG laser for all 
patients.
Study Objectives
The outcome of this study was to compare two groups in 
regard to fluctuations in systolic blood pressure (SBP), 
diastolic blood pressure (DBP), heart rate (HR), operation 
time, future stone-free rate (SFR), stone migration, 
post-operative fever, and ureteral complications such as 
perforation and mucosal damage.
Statistical Analysis
Statistical Package for Social Sciences (SPSS) software 
version 21.0 (IBM corp., Chicago, IL, USA) was used for 
statistical analysis. Quantitative variables are presented 
as mean ± standard deviation and categorical variables 
are presented as frequency and percentage. All non-
parametric comparisons were performed by chi-Square 
tests. A P value of less than 0.05 was considered statistically 
significant.
Results
Eighty-nine patients were enrolled in the sodium 
thiopental group and 91 were included in the propofol 
group. The analysis showed that the patients’ age, sex, stone 
diameter, stone laterality, duration of stone impaction, and 
baseline SBP, DBP, and HR were not significantly different 
between the two groups (P > 0.05) (Tables 1 and 2). The 
mean duration of TUL and anesthesia was significantly 
less in the propofol group than the sodium thiopental 
group (P < 0.001). The evaluation of hemodynamic 
changes showed that first-minute and fifth-minute 
SBP, DBP, and HR fluctuation were significantly less in 
the propofol group than the sodium thiopental group 
(P < 0.001) (Table 2).
Our results showed that immediate SFR was higher 
Table 1. Demographic and Clinical Characteristics of Subjects 
Variables Sodium Thiopental Group (n = 89) Propofol Group (n = 91) P Value
Mean age ± SD, (year) 47.2 ± 10.9 46.3 ± 10.4 ≥0.05
Male, No. (%) 55 (68.5) 57.1 (59) ≥0.05
Stone diameter ± SD, (mm) 8.6±1.5 8.7±1.6 ≥0.05
Stone laterality (right), No. (%) 53 (59.5) 64 (70.3) ≥0.05
Duration of stone impaction, No. (%)
1 month 58 (65.1) 70 (76.9) ≥0.05
Between 1 to 4 months 14 (15.7) 14 (15.3) ≥0.05
More than 4 months 17 (19.1) 7 (7.6) ≥0.05
TUL, transurethral lithotripsy.
Table 2. Patients’ Intraoperative and Postoperative Data
Variables Sodium Thiopental Group (n=89) Propofol  Group (n=91) P value
Mean anesthesia time ± SD, (min) 54.2±8.2 43.5±8.7 ˂0.001
Mean TUL by holmium laser time ± SD, (min) 43.2±8.2 32.5±8.7 ˂0.001
Baseline SBP (mm Hg) 138.7±12.9 136.8±13.4 0.3
Baseline DBP (mm Hg) 77±7.6 75.8±8.7 0.3
Baseline HR (BPM) 77.3±8.1 77.6±7.7 0.8
SBP (First minute) (mm Hg) 128.6±12.9 118.3±11.9 ˂0.001
DBP (First minute) (mm Hg) 73.8±7.6 65.3±10.9 ˂0.001
HR( First minute) (BPM) 90.3±8.1 67.8±9.9 ˂0.001
SBP (Fifth minute) (mm Hg) 129.7±12.9 117.1±11.9 ˂0.001
DBP (Fifth minute) (mm Hg) 73.7±7.6 62.3±10.9 ˂0.001
HR (Fifth minute) (BPM) 83±8.1 67.5±9.9 ˂0.001
Mean hospital stay ± SD, (h) 26.3±6.6 25.7±6.2 0.5
Immediate stone-free status, % 75 85 0.06
Stone migration, % 11 8 0.4
Ureteral perforation, % 4 2 0.4
Post-operative fever, % 6 8 0.7
Mucosal damage, % 19 9 0.04
SBP: systolic blood pressure, DBP: diastolic blood pressure, HR: heart rate.
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in the propofol group in comparison with the sodium 
thiopental group (P = 0.06), although this was not 
statistically significant. Furthermore, mucosal damage 
occurred significantly more in the sodium thiopental 
group compared with the propofol group (P = 0.04).
Discussion
Endoscopic treatment is most commonly used to manage 
obstructive and/or large stones. The challenges of 
intra-corporeal lithotripsy include problems associated 
with the endoscopic procedure (i.e. potential trauma 
to the urinary tract) and specific problems created by 
incomplete stone fragmentation and inadequate fragment 
elimination.16 Surgeons’ experience is a determinant 
factor in the success rate of removing ureteric calculi 
with ureteroscopic holmium laser lithotripsy and also the 
development of complications. Operations performed 
by experienced surgeons are associated with fewer 
complications and higher success rates. Factors such as 
patients’ sex, age, stone size, and location have not been 
shown to be significantly related to complications or 
success rates.17
Up to now, traditional anesthetic drugs and modalities 
have been used for the dilatation of the ureter and 
the facilitation of stone removal. Investigations are 
ongoing to seek an alternative drug which has the least 
respiratory and cardiovascular complications and also 
induces significant muscle relaxation of the ureteral wall 
and effective anesthesia. Thus, finding the best way to 
administer endoscopic treatment of ureteral stones with 
minor complications is currently a major challenge. The 
aim of this study was to assess the effect of propofol on 
the complication and success rate of TUL by holmium 
laser as compared with sodium thiopental.
In this study, the average decrease in SBP and DBP was 
more in the propofol group than the sodium thiopental 
group. However, the mean change in HR was less in the 
propofol group. In previous studies,16,18 it has been shown 
that sodium thiopental can cause a dose-dependent 
decrease in arterial blood pressure (BP), stroke volume, 
and cardiac output. These effects of sodium thiopental are 
due to the attenuation of myocardial muscles and increased 
venous return and less effect on vascular resistance.19 
On the other hand, it has been reported that during 
anesthesia with propofol, decreased vascular resistance 
and vasodilation lead to decreased blood pressure, which 
is concordant with the results of our study.20 In general, 
direct negative inotropic effects of propofol are more 
than other anesthetic agents.21 The reports of previous 
studies show that propofol is associated with a stable 
hemodynamic effect and propofol-related decrease in BP 
and HR is dose-dependent, which is consistent with our 
findings.22
It has been proposed that propofol inhibits calcium 
entrance from receptor-operated calcium channels 
(ROCCs) and voltage-operated calcium channels 
(VOCCs). In 2014, Zhong et al18 designed a study on 
the pulmonary vessel of a mouse and demonstrated 
that propofol affects both receptor-dependent and 
non-receptor-dependent pathways of smooth muscle 
contraction. Thus far, no study has investigated the 
effect of propofol on smooth muscle contraction of the 
ureteral wall. Based on previous evidence regarding the 
established effect of propofol on muscle relaxation, we 
decided to conduct a study to investigate the relaxation 
effect of propofol on the ureteral wall during the TUL 
process. Based on the results of our study, such as the 
decreased duration of TUL by holmium laser (easy and 
fast removal of stone), the higher success rate of TUL by 
holmium laser and less need for conversion into ESWL 
after TUL, we concluded that propofol might have a 
possible effect on decreasing the tonicity of the ureteral 
wall. However, we recommend further studies to confirm 
this hypothesis.
TUL is associated with disadvantages such as ureteral 
mucosal damage, urinary tract infection, sepsis, 
hematuria, post-operative increase in BP, and prolonged 
operative time. The present study showed that the 
duration of TUL by holmium laser was significantly 
less in the propofol group. Moreover, a higher SFR was 
observed in the propofol group compared with the 
sodium thiopental group. In addition, ureteral mucosal 
damage occurred significantly less in the propofol group. 
Previous studies8,18 have reported that propofol decreases 
the tonicity of upper respiratory tract muscles. Moreover, 
propofol affects calcium exchange in vascular smooth 
muscle cells and also induces endothelial nitric oxide 
release, promoting decreased muscle tone of systemic 
vessels and subsequently, vasodilation and decrease in 
BP.23 Thus, this can justify why the duration of TUL is less 
in the propofol group.
In our study, three patients developed UTI after surgery, 
treated with antibiotics. Also, hematuria occurred in two 
patients, in which the patients were treated with hydration 
and diuresis. The hematuria after TUL for these patients, 
treated and cured by serum therapy (hydration) and 
did not continue more than 1 day. In the patient who 
developed sepsis, successful treatment was achieved 
by administering antibiotics. Overall, using propofol 
during TUL by holmium laser increases the feasibility 
of this procedure as well as being associated with fewer 
complications.
Limitations of the Study
This study had some limitations. First, this was a single-
center study. Second, the patients were not controlled 
in terms of such past medical history as cardiovascular 
disease (HTN, arrhythmia, etc). Third, the sample size 
was relatively small. Thus, we recommend larger multi- 
central studies to validate the results of this study. 
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Conclusion
Based on the results of this study, applying propofol 
is associated with the higher success rate of TUL by 
holmium laser as well as fewer complications.
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